Where I see patients (5)
Selected research
-
Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
-
Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor/tezacaftor/ivacaftor: Findings from the promise study.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
-
Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Contact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program
